BRAF和RAS基因突变在甲状腺乳头状癌不同组织亚型中的表达
被引量:10
摘要
根据肿瘤有无明确的乳头状结构,甲状腺乳头状癌(PTC)通常被分为经典型和滤泡亚型,而根据肿瘤有无完整的包膜包绕,PTC又被分为浸润性和包裹性,包裹性Frc有完整的纤维包膜包绕,预后比浸润性PTC更好。BRAF、RAS基因的突变与甲状腺癌发生有着密切的联系,BRAFV600E突变在PTC中高表达,与PTC的发生和不良预后关系密切;
出处
《中华病理学杂志》
CAS
CSCD
北大核心
2015年第5期331-333,共3页
Chinese Journal of Pathology
基金
杭州市卫生科技计划项目(2012B005)
参考文献9
-
1DeLellis RA, Lioyd RV, Heitz PU, et al. WHO classification oftumours of endocrine organs[ M]. Lyon: IARC Press, 2004.
-
2Liu Z, Zhou G, Nakamura M, et al. Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well- differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal [ J]. Cancer Sci ,2011,102 ( 1 ) : 288-294.
-
3Santarpia L, Myers JN, Sherman SI, et al. Ge~aetic alterations in the RAS/RAF/ mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma[J]. Cancer,2010, 116(12) : 2974-2983.
-
4Xing M, Haugen BR, Schlumberger M. Progress in molecular- based management of differentiated thyroid cancer [ J ]. Lancet, 2013,381 (9871) :1058-1069.
-
5Kakudo K, Bai Y, Liu Z, et al. Encapsulated papillary thyroid carcinoma, follicular variant: a misnomer[J]. Pathol Int, 2012, 62(3) : 155-160.
-
6Howitt BE, Jia Y, Sholl LM, et al. Molecular alterations in partially-encapsulated or well-circumscribed follicular variant of papillary thyroid carcinoma [ J ]. Thyroid, 2013, 23 ( 10 ) : 1256- 1262.
-
7Lee SR, Jung CK, Kim TE, et al. Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing[J]. Thyroid, 2013,23( 11 ) : 1416-1422.
-
8Park JY, Kim WY, Hwang TS, et al. BRAF and RAS mutations in follicular variants of papillary thyroid carcinoma [ J ]. Endocr Pathol, 2013, 24(2) : 69-76.
-
9Jang EK, Song DE, Sim SY, et al. NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma[ J ]. Thyroid,2014, 24(8) : 1275-1281.
同被引文献152
-
1中华医学会内分泌学分会,中华医学会外科学分会内分泌学组,中国抗癌协会头颈肿瘤专业委员会,中华医学会核医学分会.甲状腺结节和分化型甲状腺癌诊治指南[J].中华核医学与分子影像学杂志,2013,33(2):96-115.
-
2Clara M. Santiveri,Lorenzo Sborgi,Eva Alba.Nuclear Magnetic Resonance study of protein–protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl‐2 members[J]. J. Mol. Recognit. . 2012 (12)
-
3Takanori Kanazawa,Ken Sugawara,Ko Tanaka,Shogo Horiuchi,Yuuki Takashima,Hiroaki Okada.Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG–PCL nanomicelles[J]. European Journal of Pharmaceutics and Biopharmaceutics . 2012 (3)
-
4Jacob Jacobsen,Lisa Rosgaard,Yumiko Sakuragi,Niels-Ulrik Frigaard.One-step plasmid construction for generation of knock-out mutants in cyanobacteria: studies of glycogen metabolism in Synechococcus sp. PCC 7002. Photosynthesis Research . 2011
-
5Gao, Congxiao,Maeno, Toshitaka,Ota, Fumi,Ueno, Manabu,Korekane, Hiroaki,Takamatsu, Shinji,Shirato, Ken,Matsumoto, Akio,Kobayashi, Satoshi,Yoshida, Keiichi,Kitazume, Shinobu,Ohtsubo, Kazuaki,Betsuyaku, Tomoko,Taniguchi, Naoyuki.Sensitivity of heterozygous α1,6-fucosyltransferase knock-out mice to cigarette smoke-induced emphysema: Implication of aberrant transforming growth factor-β signaling and matrix metalloproteinase gene expression. Journal of Biological Chemistry . 2012
-
6Czesak, Margaret,Le Fran?ois, Brice,Millar, Anne M.,Deria, Mariam,Daigle, Mireille,Visvader, Jane E.,Anisman, Hymie,Albert, Paul R.Increased serotonin-1A (5-HT1A) autoreceptor expression and reduced raphe serotonin levels in deformed epidermal autoregulatory factor-1 (Deaf-1) gene knock-out mice. Journal of Biological Chemistry . 2012
-
7Cheung L, Howlett D, El Teraifi H, et al. Association of syn- chronous medullary and papillary thyroid carcinomas with prima- ry hyperparathyroidism: First ease report and literature review ['J']. J Laryngol Otol, 2014,128(6) :565-568.
-
8Rivera M, Riearte-Filho J, Knauf J,et al. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals dis- tinct BRAF and RAS mutation patterns [J]. Mod Pathol, 2010, 23(9) : 1191-1200.
-
9Thompson RK, Gibson TN, Hanchard B,et al. Comparative a- nalysis of thyroid carcinomas in Kingston and St Andrew, Ja- maica, between two consecutive 15-year periods. [J]. West Indi- an Med J, 2011,60(5) :519-524.
-
10Derwinger K, Kodeda K, Bexe-Lindskog E,et al. Tumour dif- ferentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer I-J]. Acta Oncol, 2010,49 (1):57-62.
引证文献10
-
1曾林文,卢江昆,孔祥东,吴鸣,龚建鸣.甲状腺乳头状癌分子生物学研究进展[J].中国肿瘤临床与康复,2018,25(12):1530-1533. 被引量:7
-
2王立宏,王雯,祭美菊.甲状腺乳头状癌组织学变型与临床预后的关系[J].西部医学,2016,28(7):939-942. 被引量:4
-
3徐晓琴,王旭红,荆结线.BRAF^V600E基因突变与甲状腺乳头状癌的相关性研究进展[J].中华耳鼻咽喉头颈外科杂志,2016,51(8):630-634. 被引量:9
-
4刘少雄,掌娟,赵夫娟,鲍伟,张桂平,刘晓丹,吴畅,张金芳,凌铭,王开昕,谭敏.甲状腺乳头状癌BRAF V600E突变与RET基因重排的检测及其临床意义[J].肿瘤研究与临床,2016,28(11):721-724. 被引量:4
-
5丁金旺,王炜,张煜,韩志江,俞灵莺,雷志锴,张仕蓉,何伟,时晶晶,罗定存.甲状腺乳头状微小癌风险评估的研究进展[J].中华普通外科杂志,2016,31(12):1064-1066.
-
6王维娜,曹燕珍,陈海霞,张焕,房新志.甲状腺乳头状癌BRAF V600E基因突变与临床病理特征相关性研究[J].新疆医科大学学报,2018,41(1):79-82. 被引量:10
-
7郝金燕,刘莉萍,潘慧,王晨,岳娉.Warthin瘤样甲状腺乳头状癌的临床病理学分析[J].中华病理学杂志,2020,49(2):189-190. 被引量:5
-
8刘莉萍,郝金燕,潘慧,王晨,岳娉.RAS基因在甲状腺滤泡分化肿瘤中的突变及意义[J].中华病理学杂志,2020,49(3):256-261. 被引量:11
-
9王也,姜睿盈,底锦熙,杨磊,于芳,李洁,陈皇,王晓伟,钟定荣.RAS、BRAF、TERT基因在甲状腺细针穿刺样本中的表达特点[J].诊断病理学杂志,2020,27(11):769-774. 被引量:2
-
10王佳.RNAI-基因敲除技术及其在肿瘤研究中的进展[J].中国老年学杂志,2015,35(19):5665-5667. 被引量:2
二级引证文献53
-
1郭彦,于虹,贺慧杰.罕见实体亚型甲状腺乳头状癌1例临床病理分析[J].疾病监测与控制,2024,18(1):79-81.
-
2刘静思,廖泉.甲状腺微小乳头状癌临床病理特征与中央组淋巴结转移的相关因素研究[J].世界最新医学信息文摘,2020(25):47-48. 被引量:1
-
3杨卫民.国企改革中需要解决好的几个财务管理问题[J].现代会计,2000(1):48-48. 被引量:2
-
4马玉明.低位弧形切口在甲状腺乳头状癌颈部淋巴结转移患者术中的效果[J].社区医学杂志,2017,15(4):61-62. 被引量:4
-
5李威威,王林,曾理,李健勇.甲状腺微小乳头状癌中央组淋巴结转移与临床病理特征的关系[J].肿瘤研究与临床,2017,29(5):327-330. 被引量:8
-
6王旭红,徐晓琴,荆结线,赵宏彩,张波,高宁,张丽.BRAF^(V600E)基因突变与临床颈淋巴结阴性甲状腺乳头状微小癌中央区淋巴结转移的关系探讨[J].中国药物与临床,2017,17(9):1277-1281. 被引量:3
-
7杨帆,张海青,王敏,纪卫东,张文娟.人膀胱癌细胞RNA甲基转移酶双基因敲除模型构建与鉴定[J].中国职业医学,2017,44(6):664-670.
-
8张进科,魏有刚,李玲,朱梁军.化学治疗联合靶向COX-2 siRNA对大鼠胃癌组织JAM-1、E-cadherin及β-catenin蛋白表达的影响[J].国际消化病杂志,2018,38(1):48-53. 被引量:2
-
9刘丽云,胡月明,李岩冰,龚健.甲状腺乳头状癌中BRAF^(T1799A)基因点突变及其与临床病理特征的关系分析[J].中国普通外科杂志,2018,27(5):560-566. 被引量:1
-
10乔伟昌,王保为,孙彦.青岛地区BRAF^(V600E)基因突变型甲状腺乳头状癌的临床病理特点[J].青岛大学学报(医学版),2018,54(5):559-562. 被引量:1
-
1刘亚丽,武棣节,王文勇,李玉松.bax基因在小细胞肺癌中的表达及意义[J].细胞与分子免疫学杂志,1999,15(1):35-36. 被引量:3
-
2梅炯,蔡宣松,李日乐,汤如勇,郭荻萍.血管内皮生长因子在骨肉瘤中的表达及意义[J].上海铁道大学学报,1999,20(1):43-46.
-
3陈建钢,铁朝荣,李清,李辉.P_(53)、bcl-2和ki-67蛋白表达与涎腺腺样囊性癌关系[J].临床口腔医学杂志,1999,15(4):208-210. 被引量:1
-
4侯晓丽,陈慰浙,任国平,余新春,余心如.多房囊性肾细胞癌临床病理分析[J].实用肿瘤杂志,2004,19(3):233-235. 被引量:1
-
5刘于宝,梁长虹,王秋实,谢淑飞,余元新,刘再毅,张忠林.肝门部神经鞘瘤CT、MRI表现与病理对照分析[J].临床放射学杂志,2009,28(9):1237-1239. 被引量:6
-
6姚红霞,胡志华,苏群豪,陈志斌,李淑萍,柴玲.非何杰金淋巴瘤P16基因缺失及其与组织亚型和治疗的关系[J].西安医科大学学报,2000,21(3):229-230.
-
7王永富.肾癌不同组织亚型的CT诊断[J].山西职工医学院学报,2015,25(4):7-10.
-
8胡亚威,施鑫,吴苏稼,黄伟谦,周幸.骨肉瘤中RECK和MMP-2基因的表达及其临床意义[J].临床肿瘤学杂志,2012,17(8):708-711.
-
9徐建达,施鑫,吴苏稼,张先燎,周志平.RECK、MMP-2在骨肉瘤中的表达及其临床意义[J].临床肿瘤学杂志,2010,15(3):222-225. 被引量:6
-
10付剑韬,汤继泉,郑志鹏,于文福,王树华.肺错构瘤18例临床分析[J].牡丹江医学院学报,2007,28(1):25-26.